Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Judith Glennie"'
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-14 (2022)
Abstract Introduction Drugs for rare diseases (DRDs) offer important health benefits, but challenge traditional health technology assessment, reimbursement, and pricing processes due to limited effectiveness evidence. Recently, modified processes to
Externí odkaz:
https://doaj.org/article/bf7a810002e64db287caef8f42098cad
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 981-988 (2022)
The Canadian system for approval of new cancer drugs is complex with multiple steps. Health Canada grants a license for a drug to be marketed and prescribed. The Canadian Agency for Drugs and Technologies in Health (CADTH) and Institut national d’e
Externí odkaz:
https://doaj.org/article/635c1f2983ab4bcc981adefd52a375ba
Autor:
Nancy A Dreyer, Fadia T. Shaya, Pattra W. Mattox, Stella Blackburn, Christopher M. Marrone, Judith Glennie, Jan E. Hansen, Sarah Garner, Jack Lewin, Richard E Gliklich, Marc L. Berger, Jennifer S. Graff
Publikováno v:
Drug Information Journal. 46:185-191
The demand for real-world research (RWR) from many stakeholders has resulted in an increasing need for well-trained professionals who understand how to perform and evaluate RWR and to interpret the results of such data. The Drug Information Associati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51ead9e722fb5bbb04995f0e0bcaafb1
https://doi.org/10.1177/0092861512437760
https://doi.org/10.1177/0092861512437760